Illustrative image – not actual.Plethico Pharmaceuticals has plans to set up manufacturing
units in Russia and Kazakisthan. This decision has been taken due to the
restrictions being imposed by countries, including Russia, on imports of herbal
and protein products.
The proposed manufacturing units would entail an
investment of US$ 5 million and would be 100 per cent owned by Plethico. The units
would manufacture anti-TB products, protein supplements and herbal medicines.
Both these units are expected to come up by December 2003.
With the setting up of these units, the company would be able to establish
itself in the Commonwealth of Independent States and other countries.
Presently, the company has 5 manufacturing facilities at Indore in Madhya Pradesh. These facilities cater to both the domestic and the international markets.
